Last reviewed · How we verify
The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI
The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.
Details
| Lead sponsor | Beijing Anzhen Hospital |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 300 |
| Start date | 2015-04 |
| Completion | 2017-09 |
Conditions
- LOVASTATIN/TICAGRELOR [VA Drug Interaction]
Interventions
- Ticagrelor
- full amount low molecular weight heparin
- half amount low molecular weight heparin
- No low molecular weight heparin
Primary outcomes
- all cause mortality — one year
Countries
China